Report Detail
Global Dermal filler and Botolinum Toxin Market Insights, Forecast to 2025
- RnM3480117 |
- 31 May, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
This report studies the Dermal filler and Botolinum Toxin market, Dermal filler and Botolinum Toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
Botulinum Toxin is the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.
The global Dermal filler and Botolinum Toxin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dermal filler and Botolinum Toxin market based on company, product type, end user and key regions.
This report studies the global market size of Dermal filler and Botolinum Toxin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dermal filler and Botolinum Toxin in these regions.
This research report categorizes the global Dermal filler and Botolinum Toxin market by top players/brands, region, type and end user. This report also studies the global Dermal filler and Botolinum Toxin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Speciality European Pharma
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Market size by Product
Aesthetic Volume Restoration
Wrinkle Reduction
Market size by End User
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dermal filler and Botolinum Toxin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dermal filler and Botolinum Toxin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dermal filler and Botolinum Toxin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dermal filler and Botolinum Toxin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dermal filler and Botolinum Toxin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dermal filler and Botolinum Toxin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dermal filler and Botolinum Toxin Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dermal filler and Botolinum Toxin Market Size Growth Rate by Product
- 1.4.2 Aesthetic Volume Restoration
- 1.4.3 Wrinkle Reduction
- 1.5 Market by End User
- 1.5.1 Global Dermal filler and Botolinum Toxin Market Size Growth Rate by End User
- 1.5.2 Hyaluronic Acid Based Fillers
- 1.5.3 Non-Hyaluronic Acid Based Fillers
- 1.5.4 Botulinum Toxin
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dermal filler and Botolinum Toxin Market Size
- 2.1.1 Global Dermal filler and Botolinum Toxin Revenue 2014-2025
- 2.1.2 Global Dermal filler and Botolinum Toxin Sales 2014-2025
- 2.2 Dermal filler and Botolinum Toxin Growth Rate by Regions
- 2.2.1 Global Dermal filler and Botolinum Toxin Sales by Regions
- 2.2.2 Global Dermal filler and Botolinum Toxin Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dermal filler and Botolinum Toxin Sales by Manufacturers
- 3.1.1 Dermal filler and Botolinum Toxin Sales by Manufacturers
- 3.1.2 Dermal filler and Botolinum Toxin Sales Market Share by Manufacturers
- 3.1.3 Global Dermal filler and Botolinum Toxin Market Concentration Ratio (CR5 and HHI)
- 3.2 Dermal filler and Botolinum Toxin Revenue by Manufacturers
- 3.2.1 Dermal filler and Botolinum Toxin Revenue by Manufacturers (2014-2019)
- 3.2.2 Dermal filler and Botolinum Toxin Revenue Share by Manufacturers (2014-2019)
- 3.3 Dermal filler and Botolinum Toxin Price by Manufacturers
- 3.4 Dermal filler and Botolinum Toxin Manufacturing Base Distribution, Product Types
- 3.4.1 Dermal filler and Botolinum Toxin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dermal filler and Botolinum Toxin Product Type
- 3.4.3 Date of International Manufacturers Enter into Dermal filler and Botolinum Toxin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dermal filler and Botolinum Toxin Sales by Product
- 4.2 Global Dermal filler and Botolinum Toxin Revenue by Product
- 4.3 Dermal filler and Botolinum Toxin Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dermal filler and Botolinum Toxin Breakdown Data by End User
6 North America
- 6.1 North America Dermal filler and Botolinum Toxin by Countries
- 6.1.1 North America Dermal filler and Botolinum Toxin Sales by Countries
- 6.1.2 North America Dermal filler and Botolinum Toxin Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dermal filler and Botolinum Toxin by Product
- 6.3 North America Dermal filler and Botolinum Toxin by End User
7 Europe
- 7.1 Europe Dermal filler and Botolinum Toxin by Countries
- 7.1.1 Europe Dermal filler and Botolinum Toxin Sales by Countries
- 7.1.2 Europe Dermal filler and Botolinum Toxin Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dermal filler and Botolinum Toxin by Product
- 7.3 Europe Dermal filler and Botolinum Toxin by End User
8 Asia Pacific
- 8.1 Asia Pacific Dermal filler and Botolinum Toxin by Countries
- 8.1.1 Asia Pacific Dermal filler and Botolinum Toxin Sales by Countries
- 8.1.2 Asia Pacific Dermal filler and Botolinum Toxin Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dermal filler and Botolinum Toxin by Product
- 8.3 Asia Pacific Dermal filler and Botolinum Toxin by End User
9 Central & South America
- 9.1 Central & South America Dermal filler and Botolinum Toxin by Countries
- 9.1.1 Central & South America Dermal filler and Botolinum Toxin Sales by Countries
- 9.1.2 Central & South America Dermal filler and Botolinum Toxin Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dermal filler and Botolinum Toxin by Product
- 9.3 Central & South America Dermal filler and Botolinum Toxin by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dermal filler and Botolinum Toxin by Countries
- 10.1.1 Middle East and Africa Dermal filler and Botolinum Toxin Sales by Countries
- 10.1.2 Middle East and Africa Dermal filler and Botolinum Toxin Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dermal filler and Botolinum Toxin by Product
- 10.3 Middle East and Africa Dermal filler and Botolinum Toxin by End User
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan Dermal filler and Botolinum Toxin Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Galderma
- 11.2.1 Galderma Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Galderma Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Galderma Dermal filler and Botolinum Toxin Products Offered
- 11.2.5 Galderma Recent Development
- 11.3 Merz Pharma GmbH & Co. KGaA
- 11.3.1 Merz Pharma GmbH & Co. KGaA Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merz Pharma GmbH & Co. KGaA Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merz Pharma GmbH & Co. KGaA Dermal filler and Botolinum Toxin Products Offered
- 11.3.5 Merz Pharma GmbH & Co. KGaA Recent Development
- 11.4 Anika Therapeutics
- 11.4.1 Anika Therapeutics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Anika Therapeutics Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Anika Therapeutics Dermal filler and Botolinum Toxin Products Offered
- 11.4.5 Anika Therapeutics Recent Development
- 11.5 Suneva Medical
- 11.5.1 Suneva Medical Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Suneva Medical Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Suneva Medical Dermal filler and Botolinum Toxin Products Offered
- 11.5.5 Suneva Medical Recent Development
- 11.6 Speciality European Pharma
- 11.6.1 Speciality European Pharma Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Speciality European Pharma Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Speciality European Pharma Dermal filler and Botolinum Toxin Products Offered
- 11.6.5 Speciality European Pharma Recent Development
- 11.7 HUGEL
- 11.7.1 HUGEL Company Details
- 11.7.2 Company Business Overview
- 11.7.3 HUGEL Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 HUGEL Dermal filler and Botolinum Toxin Products Offered
- 11.7.5 HUGEL Recent Development
- 11.8 Grex Pharma
- 11.8.1 Grex Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Grex Pharma Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Grex Pharma Dermal filler and Botolinum Toxin Products Offered
- 11.8.5 Grex Pharma Recent Development
- 11.9 Daewoong Pharmaceuticals
- 11.9.1 Daewoong Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Daewoong Pharmaceuticals Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Daewoong Pharmaceuticals Dermal filler and Botolinum Toxin Products Offered
- 11.9.5 Daewoong Pharmaceuticals Recent Development
- 11.10 Medy-Tox
- 11.10.1 Medy-Tox Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Medy-Tox Dermal filler and Botolinum Toxin Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Medy-Tox Dermal filler and Botolinum Toxin Products Offered
- 11.10.5 Medy-Tox Recent Development
- 11.11 TEOXANE Laboratories
- 11.12 SciVision Biotech
12 Future Forecast
- 12.1 Dermal filler and Botolinum Toxin Market Forecast by Regions
- 12.1.1 Global Dermal filler and Botolinum Toxin Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dermal filler and Botolinum Toxin Revenue Forecast by Regions 2019-2025
- 12.2 Dermal filler and Botolinum Toxin Market Forecast by Product
- 12.2.1 Global Dermal filler and Botolinum Toxin Sales Forecast by Product 2019-2025
- 12.2.2 Global Dermal filler and Botolinum Toxin Revenue Forecast by Product 2019-2025
- 12.3 Dermal filler and Botolinum Toxin Market Forecast by End User
- 12.4 North America Dermal filler and Botolinum Toxin Forecast
- 12.5 Europe Dermal filler and Botolinum Toxin Forecast
- 12.6 Asia Pacific Dermal filler and Botolinum Toxin Forecast
- 12.7 Central & South America Dermal filler and Botolinum Toxin Forecast
- 12.8 Middle East and Africa Dermal filler and Botolinum Toxin Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dermal filler and Botolinum Toxin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dermal filler and Botolinum Toxin . Industry analysis & Market Report on Dermal filler and Botolinum Toxin is a syndicated market report, published as Global Dermal filler and Botolinum Toxin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dermal filler and Botolinum Toxin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
